Ligand Pharmaceuticals Incorporated【LGND】 株式報酬費用の推移
機能の使い方
|
（単位：千ドル）
|
株式報酬費用
|
前年比（％）
|
|
4Q25
|
14,270
|
+89.7%
|
|
3Q25
|
14,746
|
-2.8%
|
|
2Q25
|
9,997
|
-9.6%
|
|
1Q25
|
7,836
|
+6.8%
|
|
4Q24
|
7,524
|
+31.5%
|
|
3Q24
|
15,171
|
+120.4%
|
|
2Q24
|
11,060
|
+53.5%
|
|
1Q24
|
7,334
|
+23.7%
|
|
4Q23
|
5,721
|
-80.4%
|
|
3Q23
|
6,884
|
-45.4%
|
|
2Q23
|
7,207
|
-24.1%
|
|
1Q23
|
5,931
|
-34.4%
|
|
4Q22
|
29,145
|
+180.0%
|
|
3Q22
|
12,597
|
+29.1%
|
|
2Q22
|
9,499
|
-7.0%
|
|
1Q22
|
9,044
|
+7.6%
|
|
4Q21
|
10,408
|
+4.3%
|
|
3Q21
|
9,754
|
+26.0%
|
|
2Q21
|
10,216
|
+38.8%
|
|
1Q21
|
8,405
|
+48.7%
|
|
4Q20
|
9,975
|
+58.3%
|
|
3Q20
|
7,740
|
+22.9%
|
|
2Q20
|
7,359
|
+12.0%
|
|
1Q20
|
5,653
|
+5.7%
|
|
4Q19
|
6,300
|
+4.8%
|
|
3Q19
|
6,297
|
+15.1%
|
|
2Q19
|
6,571
|
+36.6%
|
|
1Q19
|
5,347
|
+17.4%
|
|
4Q18
|
6,009
|
-33.2%
|
|
3Q18
|
5,470
|
+4.2%
|
|
2Q18
|
4,812
|
+4.1%
|
|
1Q18
|
4,555
|
-24.6%
|
|
4Q17
|
8,998
|
+72.9%
|
|
3Q17
|
5,248
|
-1.6%
|
|
2Q17
|
4,624
|
+9.0%
|
|
1Q17
|
6,045
|
+46.8%
|
|
4Q16
|
5,203
|
+76.6%
|
|
3Q16
|
5,331
|
+88.0%
|
|
2Q16
|
4,241
|
+12.8%
|
|
1Q16
|
4,118
|
+41.3%
|
|
4Q15
|
2,947
|
+19.1%
|
|
3Q15
|
2,836
|
-23.4%
|
|
2Q15
|
3,761
|
+24.3%
|
|
1Q15
|
2,914
|
+41.0%
|
|
4Q14
|
2,475
|
+63.2%
|
|
3Q14
|
3,702
|
+141.5%
|
|
2Q14
|
3,026
|
+102.8%
|
|
1Q14
|
2,067
|
+83.9%
|
|
4Q13
|
1,517
|
+59.5%
|
|
3Q13
|
1,533
|
+51.3%
|
|
2Q13
|
1,492
|
+7.0%
|
|
1Q13
|
1,124
|
+58.5%
|
|
4Q12
|
951
|
+34.9%
|
|
3Q12
|
1,013
|
+6.6%
|
|
2Q12
|
1,394
|
-
|
|
1Q12
|
709
|
-
|
|
4Q11
|
705
|
-
|
|
3Q11
|
950
|
-
|